EP4247829 - GLYCOSIDE DUAL-CLEAVAGE LINKERS FOR ANTIBODY-DRUG CONJUGATES [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 25.08.2023 Database last updated on 19.10.2024 | |
Former | The international publication has been made Status updated on 27.05.2022 | Most recent event Tooltip | 26.01.2024 | Change: Validation states | published on 28.02.2024 [2024/09] | 26.01.2024 | Change - extension states | published on 28.02.2024 [2024/09] | Applicant(s) | For all designated states R.P. Scherer Technologies, LLC 112 North Curry Street Carson City NV 89703 / US | [2023/39] | Inventor(s) | 01 /
CHUPRAKOV, Stepan Emeryville, California 94608 / US | 02 /
OGUNKOYA, Ayodele O. Berkeley, California 94703 / US | [2023/39] | Representative(s) | Mewburn Ellis LLP Aurora Building Counterslip Bristol BS1 6BX / GB | [2023/39] | Application number, filing date | 21895715.7 | 19.11.2021 | [2023/39] | WO2021US60193 | Priority number, date | US202063116632P | 20.11.2020 Original published format: US 202063116632 P | US202163139685P | 20.01.2021 Original published format: US 202163139685 P | [2023/39] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2022109335 | Date: | 27.05.2022 | Language: | EN | [2022/21] | Type: | A1 Application with search report | No.: | EP4247829 | Date: | 27.09.2023 | Language: | EN | The application published by WIPO in one of the EPO official languages on 27.05.2022 takes the place of the publication of the European patent application. | [2023/39] | Search report(s) | International search report - published on: | US | 27.05.2022 | Classification | IPC: | C07H15/26, C07K5/117 | [2023/39] | CPC: |
C07K5/06034 (EP,US);
A61K47/6889 (EP,KR,US);
A61K47/6803 (KR);
A61K47/68031 (EP,US);
A61K47/68033 (EP,US);
A61K47/6813 (US);
A61K47/6817 (US);
A61K47/6829 (US);
A61K47/6831 (US);
A61K47/6849 (EP);
A61K47/6855 (EP);
A61P35/00 (KR,US);
C07H15/26 (EP,KR)
(-)
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2023/39] | Title | German: | GLYCOSID-DUALSPALTLINKER FÜR ANTIKÖRPER-WIRKSTOFF-KONJUGATE | [2023/39] | English: | GLYCOSIDE DUAL-CLEAVAGE LINKERS FOR ANTIBODY-DRUG CONJUGATES | [2023/39] | French: | LIEURS GLYCOSIDE À DOUBLE CLIVAGE POUR CONJUGUÉS ANTICORPS-MÉDICAMENT | [2023/39] | Entry into regional phase | 15.05.2023 | National basic fee paid | 15.05.2023 | Search fee paid | 15.05.2023 | Designation fee(s) paid | 15.05.2023 | Examination fee paid | Examination procedure | 15.05.2023 | Examination requested [2023/39] | 05.01.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 27.11.2023 | Renewal fee patent year 03 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2019118411 (TRIPHASE ACCELERATOR U S CORP [US]); | [A]US2019314509 (KUDIRKA ROMAS ALVYDAS [US], et al); | [A]WO2020096775 (SCHERER TECHNOLOGIES LLC R P [US]); | [XA]WO2020154437 (SCHERER TECHNOLOGIES LLC R P [US]) |